Business
Medtronic : enrolls first patient in ENDURANCE post approval study of the Altaviva™ tibial neuromodulation device
Medtronic : enrolls first patient in ENDURANCE post approval study of the Altaviva™ tibial neuromodulation
About this update from Medtronic Plc.
Medtronic announced that the first patient has been enrolled in the ENDURANCE Post-Approval Study (PAS) evaluating the Altaviva™ implantable tibial neuromodulation (ITNM) device for the treatment of urge urinary incontinence. The first study procedure was successfully performed by Vincent R. Lucente, MD, MBA, FACOG, FPMRS at Axia Women's Health in Allentown, Pennsylvania. [...] This is an abstract of the document. To keep reading, click here and get access to the original version.